Skip to main content
AAN.com
Brief Communications
July 8, 2003

Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus

July 8, 2003 issue
61 (1) 104-107

Abstract

Corticosteroid-induced psychosis occurred in 5% of a prospective cohort of 92 patients with systemic lupus erythematosus (SLE). Psychosis was unpredictable by the routes and dosage of corticosteroid used. Factors predictive of psychosis were low serum levels of albumin, complement, and creatinine; history of anxiety disorders; and a family history of psychiatric illnesses. After multivariate adjustment, only hypoalbuminemia remained significant.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf . 2000; 22: 111–122.
2.
Boston Collaborative Drug Surveillance Program. Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther . 1972; 13: 694–698.
3.
Lopez-Medrano F, Cervera R, Trejo O, Font J, Ingelmo M. Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level. Ann Rheum Dis . 2002; 61: 562–563.
4.
Olsen EA, Carson SC, Turney EA. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata. Arch Dermatol . 1992; 128: 1467–1473.
5.
Greeves JA. Rapid-onset steroid psychosis with very low dosage of prednisolone. Lancet . 1984; 1: 1119–1120.
6.
Sergent JS, Lockshin MD, Klempner MS, Lipsky BA. Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med . 1975; 58: 644–654.
7.
Joffe RT, Denicoff KD, Rubunow DR, Tsokos G, Balow JE, Pillemer SE. Mood effects of alternate-day corticosteroid therapy in patients with systemic lupus erythematosus. Gen Hosp Psychiatry . 1988; 10: 56–60.
8.
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum . 1982; 25: 1271–1277.
9.
Isshi K, Hirohata S. Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum . 1998; 41: 1819–1827.
10.
Lewis GP, Jusko WJ, Graves L, Burke CW. Prednisone side-effects and serum-protein levels. A collaborative study. Lancet . 1971; 2: 778–780.

Information & Authors

Information

Published In

Neurology®
Volume 61Number 1July 8, 2003
Pages: 104-107
PubMed: 12847167

Publication History

Received: October 7, 2002
Published online: July 8, 2003
Published in print: July 8, 2003
Accepted: December 12, 2003

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

Shuk Yi Chau, MRCP MBBS
From the Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong SAR, China.
Chi Chiu Mok, MD MRCP
From the Department of Medicine, Tuen Mun Hospital, New Territories, Hong Kong SAR, China.

Notes

Address correspondence and reprint requests to Dr. Chi Chiu Mok, Department of Medicine, Tuen Mun Hospital, Tsing Chung Koon Road, New Territories, Hong Kong; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Systemic glucocorticoid therapy for SLE, Dubois' Lupus Erythematosus and Related Syndromes, (750-762), (2025).https://doi.org/10.1016/B978-0-323-93232-5.00063-0
    Crossref
  2. Clinical application of serologic tests, serum protein abnormalities, and other laboratory tests in systemic lupus erythematosus, Dubois' Lupus Erythematosus and Related Syndromes, (673-692), (2025).https://doi.org/10.1016/B978-0-323-93232-5.00057-5
    Crossref
  3. Lupus on the Mind: A Case of Psychosis in Uncontrolled Systemic Lupus Erythematosus, Harvard Review of Psychiatry, 32, 5, (173-182), (2024).https://doi.org/10.1097/HRP.0000000000000403
    Crossref
  4. Corticosteroids and mania: A systematic review, The World Journal of Biological Psychiatry, 25, 3, (161-174), (2024).https://doi.org/10.1080/15622975.2024.2312572
    Crossref
  5. Diagnosis and Management of Pediatric Neuropsychiatric Systemic Lupus Erythematosus: An Update, Pediatric Drugs, 26, 4, (381-395), (2024).https://doi.org/10.1007/s40272-024-00632-y
    Crossref
  6. A Case of Steroid Induced Psychosis, Annals of Indian Psychiatry, 7, 3, (277-279), (2022).https://doi.org/10.4103/aip.aip_116_21
    Crossref
  7. Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions, Frontiers in Immunology, 13, (2022).https://doi.org/10.3389/fimmu.2022.957303
    Crossref
  8. Neuropsychiatric Systemic Lupus Erythematosus: A Remaining Challenge, Current Pharmaceutical Design, 28, 11, (881-891), (2022).https://doi.org/10.2174/1381612828666220512102824
    Crossref
  9. Management of non‐renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements , International Journal of Rheumatic Diseases, 25, 11, (1220-1229), (2022).https://doi.org/10.1111/1756-185X.14413
    Crossref
  10. Psychological Backgrounds of Medically Compromised Patients and Its Implication in Dentistry: A Narrative Review, International Journal of Environmental Research and Public Health, 18, 16, (8792), (2021).https://doi.org/10.3390/ijerph18168792
    Crossref
  11. See more
Loading...

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share